{
    "nctId": "NCT03162276",
    "briefTitle": "Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers",
    "officialTitle": "Evaluating the Effectiveness of Inquiry Based Stress Reduction (IBSR) Intervention Versus Regular Care of no Treatment on Well-being, Optimism and Health Behavior of BRCA1/2 Carriers: A Randomized Controlled Trial, RCT.",
    "overallStatus": "UNKNOWN",
    "conditions": "Hereditary Breast and Ovarian Cancer Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 118,
    "primaryOutcomeMeasure": "The Ryff scale- Psychological well-being",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women who are carriers of one of the predominant Jewish mutations in BRCA1/2 genes, age 25-55 years, with no current or past history of cancer (except BCC), who are willing to sign an informed consent, and present mental clarity by the ability to comprehend and fulfill all the questionnaires.\n\nExclusion Criteria:\n\n* Diagnosed with breast or ovarian cancer or any other cancer, risk reduction mastectomy, severe psychiatric diagnosis (e.g. bipolar disorder).",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT"
}